CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Impact Biomedicines

For profit

Also known as: BioMedicines

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 1

Last known activity

Dec 1, 2000

Acquired by Celgene → Bristol-Myers Squibb on Jan 8, 2018

Timeline

2010s

  1. Jan 1, 2016

    Impact Biomedicines— Founded

  2. Jan 8, 2018

    Celgene— Acquired By

  3. Jan 3, 2019

    Bristol-Myers Squibb— Now

Drugs by trial phase (2 distinct, 1 trials)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (1)

Details

Founded
San Diego, CA, US Jan 1, 2016
Last known activity
Dec 1, 2000